Latest filing published 19 Feb 2026 for Health Catalyst, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Duncan Gallagher (board member) discloses dealings in Health Catalyst, Inc. to SEC (Form 4). In total, 15 filings cover trades dated from 10 June 2021 to 17 February 2026.
In open-market terms, that means 1 purchase worth €97k on one side and 2 sales worth €60k on the other. On balance, insiders were net buyers of €37k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 12 share grants.
The latest filing, published on 19 February 2026, reports a share grant in Health Catalyst, Inc. The clock since the last published purchase (19 August 2022) now reads 1,521 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations